AI assistant
STANDARD BIOTOOLS INC. — Director's Dealing 2012
Nov 28, 2012
32853_dirs_2012-11-28_c8982dbb-6cd0-467c-89b9-ae138178168e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: FLUIDIGM CORP (FLDM)
CIK: 0001162194
Period of Report: 2012-11-26
Reporting Person: JONES ROBERT C (EVP, Research & Development)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-11-26 | Common Stock | M | 3070 | $3.3908 | Acquired | 3070 | Direct |
| 2012-11-26 | Common Stock | S | 3070 | $14.5079 | Disposed | 0 | Direct |
| 2012-11-27 | Common Stock | M | 5830 | $3.3908 | Acquired | 5830 | Direct |
| 2012-11-27 | Common Stock | S | 5830 | $14.3811 | Disposed | 0 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2012-11-26 | Employee Stock Option (Right to Buy) | $3.3908 | M | 3070 | Disposed | 2015-08-02 | Common Stock (3070) | Direct |
| 2012-11-27 | Employee Stock Option (Right to Buy) | $3.3908 | M | 5830 | Disposed | 2015-08-02 | Common Stock (5830) | Direct |
Footnotes
F1: The sales reported by Mr. Jones were effected pursuant to a Rule 10b5-1 trading plan adopted on February 24, 2012.
F2: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $14.33 to $14.64, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
F3: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $14.2266 to $14.525, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
F4: The shares subject to the Option fully vested on August 1, 2009.